Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP4A | P20648 | 2/20 | 0.57 |
| ▸ | ATP4B | P51164 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | HK1 | P19367 | 1/20 | 0.51 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | C1S | P09871 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30087395 | 1.00 | ATP4A (0.57) | ATP4AATP4BMAPTRAB9AALDH1A1 | |
| SCHEMBL8257849 | 0.84 | RECQL (0.70) | ATP4AATP4BMAPTRAB9AALDH1A1 | |
| SCHEMBL7120830 | 0.82 | ALDH1A1 (0.65) | ATP4AATP4BMAPTRAB9AALDH1A1 | |
| SCHEMBL4076416 | 0.81 | ALDH1A1 (0.74) | MAPTRAB9AALDH1A1HPGDHK1 | |
| SCHEMBL9454811 | 0.81 | ATP4A (0.56) | ATP4AATP4BMAPTRAB9AALDH1A1 | |
| SCHEMBL19196250 | 0.80 | ALDH1A1 (0.53) | MAPTRAB9AALDH1A1HPGDHK1 | |
| SCHEMBL12868318 | 0.79 | ATP4A (0.55) | ATP4AATP4BMAPTRAB9AALDH1A1 | |
| SCHEMBL19051397 | 0.79 | SREBF2 (0.71) | ATP4AATP4BMAPTRAB9AALDH1A1 | |
| SCHEMBL3764574 | 0.79 | KDM4E (0.70) | MAPTRAB9AALDH1A1HPGDHK1 | |
| SCHEMBL25735690 | 0.79 | TSHR (0.68) | MAPTRAB9AALDH1A1HPGDHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130921-A1 | TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS | AcuraStem Incorporated (US) | 2026-05-14 | — | — | US | disclosed |
| US-20240352026-A1 | PIKFYVE KINASE INHIBITORS | AcuraStem Incorporated | 2024-10-24 | — | — | US | disclosed |
| US-20240197747-A1 | TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS | AcuraStem, Inc. (US) | 2024-06-20 | — | — | US | disclosed |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| EP-4103281-A1 | PIKFYVE KINASE INHIBITORS | Acurastem Inc. (US) | 2022-12-21 | — | — | EP | disclosed |
| CN-113912595-A | Compound containing thiazole or thiadiazole structure and application thereof | 中国药科大学 | 2022-01-11 | — | — | CN | disclosed |
| US-20210338683-A1 | TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-11-04 | — | — | US | disclosed |
| WO-2021163727-A1 | PIKFYVE KINASE INHIBITORS | AcuraStem Incorporated (US) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021163727-A1 | PIKFYVE KINASE INHIBITORS | AcuraStem Incorporated (US) | 2021-08-19 | — | — | WO | disclosed |
| EP-3676264-A1 | PIKFYVE KINASE INHIBITORS | Acurastem Inc. (US) | 2020-07-08 | — | — | EP | disclosed |
| US-20200199136-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-06-25 | — | — | US | disclosed |
| WO-2019046316-A1 | PIKFYVE KINASE INHIBITORS | ACURASTEM INC. (US) | 2019-03-07 | — | — | WO | disclosed |
| US-8461348-B2 | Heterocyclic derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-06-11 | — | — | US | disclosed |
| US-20110028493-A1 | HETEROCYCLIC DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-02-03 | — | — | US | disclosed |
| US-7851473-B2 | Amide compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20080312226-A1 | Amide Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1813606-A1 | AMIDE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2007-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | PIKFYVE, PIP5K1B, PIP5K1C | ATP4A 2357/4885ATP4B 2648/4885MAPT 1501/4885 |
| US-20200199136-A1 | PIKFYVE KINASE INHIBITORS | PIKFYVE, PIP5K1B, PIK3CA | ATP4A 2021/4885ATP4B 2529/4885MAPT 1959/4885 |
| US-20080312226-A1 | Amide Compound | FAAH, FAAH2, CNR2 | ATP4A 1719/4885ATP4B 2624/4885MAPT 3805/4885 |
| US-20240352026-A1 | PIKFYVE KINASE INHIBITORS | PIKFYVE, PIP5K1B, PIK3CA | ATP4A 2021/4885ATP4B 2529/4885MAPT 1959/4885 |
| US-20240197747-A1 | TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS | PIKFYVE, TMPRSS2, TMPRSS4 | ATP4A 3163/4885ATP4B 2406/4885MAPT 2796/4885 |
| US-20110028493-A1 | HETEROCYCLIC DERIVATIVE AND USE THEREOF | PDE3B, PDE5A, PDE2A | ATP4A 2758/4885ATP4B 2711/4885MAPT 4667/4885 |
| US-20260130921-A1 | TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS | TMPRSS2, TMPRSS11D, TMPRSS6 | ATP4A 1543/4885ATP4B 1101/4885MAPT 2715/4885 |
| US-20210338683-A1 | TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS | PIKFYVE, TMPRSS2, TMPRSS4 | ATP4A 3163/4885ATP4B 2406/4885MAPT 2796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.